CD274 and neoplasm: However, the anti-tumor activity of these cells is partially inhibited by immunological checkpoints, such as the PD-1/PD-L1 interaction axis, and other immune cells, such as regulatory T cells, M2-macrophages and a number of other factors that induce a prevailing immunosuppressive state (1), favoring the tumor.